Application of ddx20 in the preparation of postoperative prognosis assessment kit for clear cell renal cell carcinoma
A technology of renal clear cell carcinoma and DDX20, which is applied in the field of application of DDX20 in the preparation of postoperative prognosis assessment kits for renal clear cell carcinoma, which can solve the problems of lack of specific molecular targets and unclear molecular mechanisms in the treatment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] (a) Pathological specimens were obtained from biopsies or intraoperative and postoperative pathological materials of patients with clear cell renal cell carcinoma.
[0043] (b) The immunohistochemical method uses the SP staining method, and the specific steps are as follows:
[0044] (c) Paraffin sections of renal clear cell carcinoma tissues were prepared, and the oven was set at 60° C. overnight.
[0045] (d) Dewaxing of slices. Soak in sequence: Xylene I: 10min; Xylene II: 10min; Xylene III: 10min.
[0046] (e) Section hydration. Soak in sequence: absolute ethanol: 3min; 90% (v / v) ethanol: 3min; 80% ethanol: 3min; 75% ethanol: 3min.
[0047] (f) Washing with PBS 3 times, 5 min each time.
[0048] (h) EDTA antigen high-pressure repair: soak the slices in 0.01M EDTA repair solution, soak in boiling water for 5 minutes, and cool to room temperature. Wash 3 times with PBS, 5min each time.
[0049] (I) Add 300 μL of 3% (w / w) hydrogen peroxide aqueous solution, 37° C. ...
Embodiment 2
[0065] A postoperative tumor sample of clear cell renal cell carcinoma was taken for paraffin-embedded section, and the immunohistochemical method described above was used for detection. After calculation, the DDX20 immunohistochemical score of the cancer tissue was 0.632. After postoperative follow-up, it was found that the patient had recurrence and metastasis of renal clear cell carcinoma at the 40th month after the operation, and died 48 months after the operation.
Embodiment 3
[0067] A postoperative tumor sample of clear cell renal cell carcinoma was taken for paraffin-embedded section, and the above-mentioned immunohistochemical method was used for detection. After calculation, the DDX20 immunohistochemical score of the cancer tissue was 0.299. After postoperative follow-up, it was found that the patient was alive without metastasis and recurrence 5 years after the operation.
[0068] From the above test results, it can be known that detecting the relative expression of DDX20 molecules by immunohistochemistry can predict the risk of distant metastasis of renal clear cell carcinoma and the postoperative survival or death of patients. When the DDX20 immunohistochemical score of cancer tissue is higher than 0.452, clear cell renal cell carcinoma is prone to recurrence and metastasis, and patients with clear cell renal cell carcinoma are prone to die after operation. Obviously, DDX20 is related to clear cell renal cell carcinoma. Therefore, detection o...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com